Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis
Background For patients with MS, medication switches increase the risk of disease reactivation. Objective Compare discontinuation rates due to treatment failure or side effects between teriflunomide and dimethyl fumarate, and investigate clinical variables affecting discontinuation rates. Methods Al...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publishing
2021-06-01
|
| Sarja: | Multiple Sclerosis Journal - Experimental, Translational and Clinical |
| Linkit: | https://doi.org/10.1177/20552173211022027 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|